Seeing Is Believing
Forma Therapeutics Holdings's activity chart (see below) currently has 25 price targets and 22 ratings on display.
Analysts average stock forecasts to be materialized ratio is 15.38% with an average time for these price targets to be met of 18.92 days.
Most recent stock forecast was given by MARK BREIDENBACH from OPPENHEIMER on 02-Sep-2022. First documented stock forecast 14-Jul-2020.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 17-Feb-2021
$49
4 years 29 days ago
(02-Sep-2022)
0/3 (0%)
$39.17 (398.47%)
Buy Since 15-Jun-2021
$20
$-0.01 (-0.05%)
$40
4 years 29 days ago
(02-Sep-2022)
1/2 (50%)
$0.02 (0.10%)
41
Buy Since 14-Jul-2020
$20
$-0.01 (-0.05%)
$62
4 years 29 days ago
(02-Sep-2022)
1/4 (25%)
$0.02 (0.10%)
41
Buy Since 08-Sep-2020
$20
$-0.01 (-0.05%)
$53
4 years 29 days ago
(02-Sep-2022)
1/4 (25%)
$0.02 (0.10%)
41
Buy Since 13-Jun-2022
$21
$0.99 (4.95%)
4 years 3 months 18 days ago
(13-Jun-2022)
0/1 (0%)
$15.82 (305.41%)
What is FMTX (Forma Therapeutics Holdings) average time for price targets to be met?
Which analyst most recently updated their price target on FMTX (Forma Therapeutics Holdings)?
Which analyst has the most public recommendations on FMTX (Forma Therapeutics Holdings)?
Which analyst is the currently most bullish on FMTX (Forma Therapeutics Holdings)?
Which analyst is the currently most reserved on FMTX (Forma Therapeutics Holdings)?